Myriad Genetics
MYGN
#7310
Rank
$0.56 B
Marketcap
$5.92
Share price
-5.88%
Change (1 day)
-8.64%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2023 (TTM): -$3.04

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -$1.19. In 2022 the company made an earnings per share (EPS) of -$1.39 a decrease over its 2021 EPS that were of -$0.37.

EPS history for Myriad Genetics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.04118.71%
2022-$1.39275.68%
2021-$0.37-87.99%
2020-$3.08755.56%
2019-$0.36-194.74%
2018$0.38-79.89%
2017$1.89112.36%
2016$0.89-35.97%
2015$1.39-7.33%
2014$1.50-37.24%
2013$2.3959.33%
2012$1.5020.97%
2011$1.24-10.79%
2010$1.3914.88%
2009$1.2112.04%
2008$1.08-454.1%
2007-$0.30-42.45%
2006-$0.53-8.62%
2005-$0.58-18.88%
2004-$0.7222.22%
2003-$0.5825.81%
2002-$0.46200%
2001-$0.16-13.89%
2000-$0.18-20.88%
1999-$0.23-24.79%
1998-$0.3061.33%
1997-$0.19-34.21%
1996-$0.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
$2.70-327.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-$5.32 347.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$50.90 4,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$8.33-800.00%๐Ÿ‡บ๐Ÿ‡ธ USA